Solid Biosciences (SLDB)Chief Medical Officer sold ~$19K
Gabriel Brooks, Chief Medical Officer at Solid Biosciences, sold ~$19K of Solid Biosciences shares.
- ~$19K
- Approx. value · 2,923 sh @ $6.50
- 11K
- Holds after · shares reported
- Traded
- Oct 21, 2024
- Filed
- Oct 22, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 21, 2024 · this disclosureInsiderOfficer sold ~$19K of SLDB shares in the open market
What came next
- Dec 3, 2024Insider · 4 peopleInsiders: 4 sales (~$132K)
- Jan 6, 2025InsiderDirector sold ~$4.6K of SLDB shares in the open market
- Jan 10, 2025InsiderCFO sold ~$16K of SLDB shares in the open market
- Jan 28, 2025InsiderDirector sold ~$448 of SLDB shares in the open market
- Feb 14, 2025Insider · 7 peopleInsiders: 7 sales (~$122K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Solid Biosciences
For Solid Biosciences, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SLDB page.
Other recent filings by Gabriel Brooks, Chief Medical Officer
The full history of Gabriel Brooks, Chief Medical Officer is on the profile page.
How this filing works
Other disclosures at Solid Biosciences
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 13F-HRAug 14, 2025
Everything OQRO holds on this company is on its SLDB page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data